-
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial
Toorop, A. A., Wessels, M. H. J., Gelissen, L. M. Y., Hoitsma, E., Zeinstra, E. M. P. E., van Rooij, L. C., van Munster, C. E. P., Vennegoor, A., Mostert, J. P., Wokke, B. H. A., Kalkers, N. F., Hoogervorst, E. L. J., van Eijk, J. J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L. G. F., Kloosterziel, M. E., & 11 others, 15 Jul 2024, In: Journal of the neurological sciences. 462, p. 123102 123102.Research output: Contribution to journal › Article › Academic › peer-review
-
Successful treatment of respiratory failure in Hirayama disease
Sol, N., Hartman, J., ten Kate, M., van Kempen, Z., van der Kooi, A., Vandertop, P., Tuinman, P-R. & van Oosten, B., 1 Feb 2024, In: American Journal of Emergency Medicine. 76, p. 272.e3-272.e5Research output: Contribution to journal › Article › Academic › peer-review
-
Successful treatment of respiratory failure in Hirayama disease
Sol, N., Hartman, J., ten Kate, M., van Kempen, Z., van der Kooi, A., Vandertop, P., Tuinman, P. R. & van Oosten, B., Feb 2024, In: American Journal of Emergency Medicine. 76, p. 272.e3-272.e5Research output: Contribution to journal › Article › Academic › peer-review
- All publications
